RANDOLPH NACE: Open Payments
NPI 1831873173 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 32 payments from 8 companies in 2025. Trend: 2023 $69 · 2024 $358 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $148 |
| Corium, LLC | 6 | $144 |
| Supernus Pharmaceuticals, Inc. | 14 | $108 |
| Collegium Pharmaceutical, Inc. | 3 | $46 |
| Tris Pharma Inc | 2 | $38 |
| ACADIA Pharmaceuticals Inc | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: INGREZZA, Azstarys, Qelbree, Jornay PM, Dyanavel XR, DAYBUE, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
